home / stock / novn / novn quote
Last: | $0.0941 |
---|---|
Change Percent: | -45.38% |
Open: | $0.1368 |
Close: | $0.0941 |
High: | $0.1396 |
Low: | $0.082 |
Volume: | 7,190,009 |
Last Trade Date Time: | 07/25/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0941 | $0.1368 | $0.0941 | $0.1396 | $0.082 | 7,190,009 | 07-25-2023 |
$0.1252 | $0.1305 | $0.1252 | $0.137 | $0.1242 | 1,719,218 | 07-24-2023 |
$0.14 | $0.15 | $0.14 | $0.1568 | $0.122 | 3,003,129 | 07-21-2023 |
$0.162 | $0.1698 | $0.162 | $0.1745 | $0.1549 | 3,702,134 | 07-20-2023 |
$0.177 | $0.17 | $0.177 | $0.1939 | $0.16 | 12,230,017 | 07-19-2023 |
$0.1684 | $0.1572 | $0.1684 | $0.174 | $0.15 | 6,895,908 | 07-18-2023 |
$0.18 | $0.2253 | $0.18 | $0.23 | $0.15 | 14,864,681 | 07-17-2023 |
$0.611 | $0.5813 | $0.611 | $0.623 | $0.5608 | 402,928 | 07-14-2023 |
$0.5617 | $0.554 | $0.5617 | $0.595 | $0.55 | 378,443 | 07-13-2023 |
$0.536 | $0.6252 | $0.536 | $0.6252 | $0.532 | 388,679 | 07-12-2023 |
$0.5704 | $0.6108 | $0.5704 | $0.621 | $0.56 | 399,370 | 07-11-2023 |
$0.5704 | $0.507 | $0.5704 | $0.6 | $0.484201 | 1,159,207 | 07-10-2023 |
$0.4699 | $0.457 | $0.4699 | $0.4779 | $0.45 | 183,839 | 07-07-2023 |
$0.46 | $0.5 | $0.46 | $0.5 | $0.4515 | 241,723 | 07-06-2023 |
$0.48 | $0.4841 | $0.48 | $0.5078 | $0.4675 | 367,263 | 07-05-2023 |
$0.4841 | $0.44 | $0.43 | $0.485 | $0.4351 | 183,810 | 07-04-2023 |
$0.4841 | $0.44 | $0.4841 | $0.485 | $0.4351 | 183,810 | 07-03-2023 |
$0.43 | $0.468 | $0.43 | $0.487899 | $0.43 | 674,935 | 06-30-2023 |
$0.468 | $0.5086 | $0.468 | $0.52 | $0.45 | 861,439 | 06-29-2023 |
$0.4586 | $0.408 | $0.4586 | $0.49 | $0.4064 | 805,052 | 06-28-2023 |
News, Short Squeeze, Breakout and More Instantly...
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along with a commitment from Ligand to fund $15 million in debtor-in-possession financing – – Progression toward...
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6...
– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business transaction continues – – Continued progress ...